CIBC Bancorp USA’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
CIBC Bancorp USA's TXG Position: Q3 2026 in Review
CIBC Bancorp USA increased its 10x Genomics (TXG) stake by 76% in Q3 2026, buying an estimated $294K and bringing the position to 11,607 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1099.
CIBC Bancorp USA first reported a position in TXG in Q3 2025 and has held it in 3 quarters since. 482 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- CIBC Bancorp USA held 11,607 shares of 10x Genomics worth $1.05M as of Q3 2026.
- CIBC Bancorp USA bought 5,024 10x Genomics shares in Q3 2026, an estimated $294K.
- 10x Genomics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1099 holding.
- CIBC Bancorp USA first reported a position in 10x Genomics in Q3 2025 and has held it in 3 quarters since.
- 482 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.